Compound · clinical trials

PCV20 clinical trials

Also listed in trial records as V118C, Stage 1, Stage 2, 177Lu-NRT6020, Stage 3

Source: ClinicalTrials.gov, U.S. National Library of Medicine — the 4 trials in our USA and China registers that name PCV20 as an intervention. Synced 9 Nov 2026

4Current trials

2Recruiting now

3Lead sponsors

2Country registers

Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist

Compiled from ClinicalTrials.gov registry records · Synced 9 Nov 2026 · Editorial standards

At a glance

PCV20 is named as an intervention in 4 current clinical trials in our USA and China registers. 2 are recruiting patients now. The most common phase is Phase 1. The sponsor with the most trials is Vaxcyte, Inc (2). The most-studied condition is Pneumococcal Vaccines.

Patient leaflets for PCV20

The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.

UK
United Kingdom: Search MHRA Products
Patient information leaflets and SmPCs for UK-licensed products.
US
United States: Search DailyMed
FDA-approved labels, including patient and medication guides.

Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.

Trials by status

Recruiting250%
Active, closed250%

Trials by phase

Phase 1250%
Phase 3125%
Phase 2125%

Clinical trials of PCV20

4 trials

Study	Phase	Status	Lead sponsor	Registers
Safety Trial of 68Ga/177Lu-NRT6020 in FAP-Positive Advanced Solid Tumor Patients NCT06911489 · ClinicalTrials.gov ↗ · Solid Tumor Malignancy	Phase 1	Recruiting	Chengdu New Radiomedicine Technology Co. LTD	China
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002) NCT07300267 · Pneumococcal Infection	Phase 1	Recruiting	Merck Sharp & Dohme LLC	USA
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prior Pneumococcal Vaccination NCT07425392 · Pneumococcal Vaccines	Phase 3	Active, closed	Vaxcyte, Inc	USA
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants NCT06720038 · Pneumococcal Vaccines	Phase 2	Active, closed	Vaxcyte, Inc	USA

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.

Conditions studied with PCV20

3 conditions

Pneumococcal Vaccines2Pneumococcal Infection1Solid Tumor Malignancy1

By country register

Register	Trials	Recruiting
Clinical trials in USA	3	1
Clinical trials in China	1	1

A trial with sites in more than one country appears in each of those registers.

Related compounds

Questions about PCV20 trials

How many clinical trials are testing PCV20?

4 current trials in our USA and China registers name PCV20 (also registered as V118C) as a drug or biological intervention, as of the registry sync on 9 November 2026. Completed and withdrawn studies are not counted.

Are PCV20 trials recruiting patients?

Yes. 2 of the 4 trials are recruiting: 1 with sites in USA and 1 with sites in China. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Who sponsors PCV20 clinical trials?

Vaxcyte, Inc (2), Merck Sharp & Dohme LLC (1) and Chengdu New Radiomedicine Technology Co. LTD (1). The number in brackets is how many trials each organisation leads.

Where does this information come from?

Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how PCV20 works or whether it is effective, and it is not medical advice.

How this page is built

Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how PCV20 works or whether it is effective. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page

This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists PCV20 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 9 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.